000 03306nam a2200409 c4500
999 _c6017
_d6017
001 6017
003 ES-MaUEC
005 20200703165755.0
006 a||||fo|||| 00| 0
007 cr nn nnnanaaa
008 190826s2020 gw a o |||| 0|eng d
020 _a9783319645131
024 7 _a10.1007/978-3-319-64513-1
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRC280.U8
_b.M36 2020 EB
245 0 0 _aManagement of Endometrial Cancer
_cedited by Mansoor R. Mirza.
250 _a1st ed. 2020.
264 1 _aCham
_bSpringer International Publishing :
_bImprint: Springer
_c2020.
300 _a1 recurso en línea (VIII, 324 páginas)
_b200 ilustraciones, 100 ilustraciones a color
336 _2rdacontent
_aTexto
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
490 0 _aMedicine (Springer-11650)
505 0 _aFIGO classification of endometrial cancer -- Epidemiology, risk factors and need for cancer registry -- Hormonal interactions in endometrial cancer -- Endometrial cancer prevention -- Controversies in pathology.- Hereditary cancers.- Genetic classification & it's clinical applications.- Advances in endometrial cancer diagnosis.- Need for level-one evidence in the management of endometrial cancer.- Summery of ESMO-ESGO-ESTRO consensus guidelines for the management of endometrial cancer.- Summery of SGO-NCCN management guidelines.- Risk factors in the early stage endometrial cancer -- Surgical principles -- Radiation therapy in endometrial cancer -- Role of chemotherapy -- Endocrine therapy of endometrial cancer -- Targeted therapy -- Management of rare tumours -- Quality of life. .
520 3 _aThis practical reference book provides up-to-date, evidence-based multidisciplinary guidelines on the epidemiology, biology, diagnosis, and treatment of endometrial cancer. Individual chapters focus on topics such as hormonal interactions, cancer prevention, genetic classification and its clinical applications. Recent advances in diagnostic methods are described. The treatment-oriented chapters include coverage of the roles of lymphadenectomy and sentinel node dissection, surgical complications, radiation techniques, and chemotherapy in early-stage disease. Treatment options in advanced disease, including hormonal therapy and targeted therapy, are considered separately, as is the management of rare tumor types. The authors are international key opinion leaders. Summaries of the ESMO/ESGO/ESTRO guidelines on management are included. Each clinical chapter ends with a summary of recommendations with the level of evidence.
988 _aSegundosemestre_2019_Medicine
650 7 _2embne
_9182312
_aÚtero
_xCáncer
700 1 _aMirza, Mansoor R
_eeditor
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
_9106937
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9783319645124
776 0 8 _iPrinted edition:
_z9783319645148
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-64513-1
_zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942 _2lcc
_cLE
998 _db
_feng
_ggw
_h0
_ea
_zSI